Saving lives with breath aerosol diagnostics


The need

  • Up to 20% of all primary care consultations are due to respiratory infections¹ ​​​

  • They result in 4 million deaths each year, almost all of them due to infections in the lower respiratory tract causing pneumonia²

  • Lack of good diagnostic solutions are a main reason for poor outcomes and antibiotic overuse

  • Transformative, rapid testing where people first seek care is needed to capture pneumonia early and initiate the right treatment


Our solution 

A non-invasive sample-to-answer breath test that reliably detects multiple lower respiratory tract infections in primary care within minutes in three simple steps:

1. Collect


Breathe for

2 minutes

2. Detect



multiple diseases

3. Act


Take the right


The impact

  • Saving lives by earlier appropriate antibiotic or antiviral treatment and rapid patient referral

  • Reducing healthcare costs: Avelo's rapid test results help to lower the annual costs of USD 52 billion in Europe alone by keeping patients out of the hospital³

  • Fighting antimicrobial resistance (AMR): Avelo's test differentiates between viral and bacterial infections to assist in antibiotic stewardship and reduce the > 65% unnecessarily prescribed antibiotics in primary care⁴

  • Establishing self-collected breath bioaerosols as a novel diagnostic sample type for new testing solutions